1. Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma

Volume 23, Issue 6, June 2022, Pages 2079-2087

Heba Khalil; Olfat Ali Hammam; Amira Kamel

• View Article
• PDF 1.86 MB

2. Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review

Volume 18, Issue 2, February 2017, Pages 459-463

Ali Koyuncuer

• View Article
• PDF 771.13 K

3. Application of a Network Scale-up Method to Estimate the Size of Population of Breast, Ovarian/Cervical, Prostate and Bladder Cancers

Volume 16, Issue 8, August 2015, Pages 3273-3277

• View Article
• PDF 353.08 K

4. Gemcitabine Plus Nedaplatin as Salvage Therapy is a Favorable Option for Patients with Progressive Metastatic Urothelial Carcinoma After Two Lines of Chemotherapy

Volume 16, Issue 6, June 2015, Pages 2483-2487

• View Article
• PDF 481.99 K

5. High Expression Level of Preoperative Serum Uroplakin III is Associated with Biologically Aggressive Bladder Cancer.

Volume 16, Issue 4, April 2015, Pages 1539-1543

• View Article
• PDF 526.33 K